iron repletion on reduction of the primary endpoint (RR = 0.71; 95% CI 0.57–0.87, p = 0.001) compared to patients with non-ischemic heart disease (RR = 0.97; 95% CI 0.75–1.26, p = 0.83) as p for interaction of 0.06 showed a trend toward significance (Fig.
← all excerpts
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis.
1
—
—